GLP-1 & Dual-Agonist Weight Loss Therapies

REVRCEL's weight-loss protocols use compounded GLP-1 and dual-agonist therapies — semaglutide and tirzepatide — prescribed and titrated by a licensed clinician and dispensed to a patient-specific prescription through a PCAB-accredited 503A compounding pharmacy partner. Each plan begins with a full metabolic workup, so therapy is appropriate, titrated, and monitored against ongoing labs.

Loading…